Delivery Order SPE2DB22D3401-SPE2DB26FT0RF
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Dificid 200 mg tablets (20-count units) with a contract ceiling value of $15,984.50. This firm fixed-price delivery order, which is expected to be completed by September 10, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical. The award utilized no set-aside designation and was competitively...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for Dificidin 200 mg tablets (20-count packaging) valued at $2,713.06 with a firm fixed price arrangement. This non-competitive delivery order is set to conclude by November 7, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Dificidin 200 mg tablets (20-count packaging) valued at $9,919.68 under a firm fixed-price arrangement. This non-set-aside contract was competitively awarded and is scheduled for completion by September 23, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for DIFICID 200 mg tablets (20-count units) with a ceiling value of $36,164.77. This competitive, firm fixed-price delivery order was executed on September 17, 2025, with an ultimate completion date of September 18, 2025, and represents performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was awarded through...
- This delivery order, valued at $53,563.14, was awarded on September 16, 2025, to AmerisourceBergen Drug Corp for the supply of Dificid 200 mg tablets in quantities of 20 tablets. The contract is a firm fixed price delivery order with no set-aside designation, issued competitively under the Defense Logistics Agency's Medical Supply Chain organization. Performance will be executed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,713.06 to AmerisourceBergen Drug Corp for Dificid 200 mg tablets (20-count packaging) on November 6, 2025, with an ultimate completion date of November 7, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitively awarded procurement under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,261.46 to AmerisourceBergen Drug Corp for DIFICIDIN 200 mg tablets (20-count packages) on September 3, 2025, with an ultimate completion date of September 4, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract with performance to be fulfilled at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The order is issued under AmerisourceBergen's larger Indefinite...
- The U.S. Defense Logistics Agency (DLA) awarded a $7,492.05 delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of DIFICID 200 MG TABLET 20S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply 4,564,249,121 units of DIFICID 200 MG TABLET 20S. The $8,831.37 contract has an ultimate completion date of April 12, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through...
- The U.S. Defense Logistics Agency Troop Support Medical has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide DIFICID 200 mg tablets. The contract has a completion date of February 6, 2024 and a potential value of $3,631.01. This delivery order is likely part of a larger indefinite delivery contract (IDC) that AmerisourceBergen Drug Corp holds with DLA Troop Support Medical, with a potential value of up to...
- SPE2DB22D3401Indefinite Delivery Contract
- SPE2DB22D3401-SPE2DB26FT0RFDelivery Order
The Defense Logistics Agency awarded a $31,066.43 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dificid 200 mg tablets (20-count units) on November 6, 2025, with an ultimate completion date of November 7, 2025. The contract is unclassified as a set-aside and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was competitively selected through open competition to fulfill this federal medical supply requirement. The company's extensive portfolio with the Defense Logistics Agency demonstrates its capability to supply critical pharmaceuticals across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Dificid (fidaxomicin), an antibiotic used primarily to treat Clostridioides difficile infections, represents one of many specialized medications the contractor routinely delivers under its prime vendor agreement with DLA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $31.1k | 11/6/25 |